Heart of Automation: Inside an AC Contactor FactoryAfter delay, Trump signs agreement with Biden White House to begin formal transition handoffLOWELL, Mass.--(BUSINESS WIRE)--Dec 11, 2024-- RevBio, Inc., announced that it has received FDA approval to expand its ongoing clinical trial to immediately fixate cranial flaps using TETRANITE ®, the company’s bone adhesive biomaterial. The company also received reimbursement coverage from the Centers for Medicare and Medicaid (“CMS”) for the use of TETRANITE to replace metal plates and screws. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211734903/en/ The computed tomography (CT) image on the left shows a patient who received TETRANITE® to fixate their cranial flap three months following brain surgery. On the right, a post-operative CT scan of the same patient six months following their surgery shows the conformal nature of the skull restoration and the reintegration of the flap with the surrounding bone. (Photo: Business Wire) Previously, RevBio received FDA approval to initiate a first-in-human clinical study for an initial five patients to restore cranial flaps following craniotomy procedures and to repair extradural use cases where intentional durotomies are not required. The approval of this clinical trial expansion is a result of the successful demonstration of safety in the first five patients treated with TETRANITE. The neurosurgeon investigators involved in this study will now be able to use TETRANITE in intradural use cases, such as tumor resection surgeries and other cranial procedures, which require intentional durotomies. “Metal plates and screws can produce radiographic artifacts which make it difficult to accurately interpret patient imaging following surgery. Furthermore, traditional cranial flap closure methods do not lead to the full osseous reintegration of the flap with the skull, resulting in issues with flap movement, patient pain, and the potential for post-surgical infection. Because TETRANITE eliminates radiographic artifacts and results in osseous union of bone flaps with the surrounding skull, it could become the new standard of care for cranial surgeries,” said Kevin T. Foley, MD, professor in the Departments of Neurosurgery and Orthopedic Surgery & Biomedical Engineering at the University of Tennessee Health Science Center in Memphis, Tennessee, Chairman of Semmes-Murphey Clinic, and Chairman of the Board and Medical Director for the Medical Education & Research Institute (MERI). Dr. Foley also serves as a member of the Board of Directors and Chief Medical Officer for RevBio. Furthermore, in conjunction with the clinical trial expansion, the Centers for Medicare and Medicaid approved TETRANITE for medical insurance reimbursement when used to replace metal plates and screws for cranial flap fixation. Private insurance companies will also typically provide reimbursement for CMS approved products. As a result, RevBio can now charge hospitals for this product. “We are pleased to receive reimbursement approval from CMS during our IDE clinical trial,” said Grayson Allen, CFO/COO of RevBio. “This will enable RevBio to establish a price with healthcare providers, which is a very important step in the overall product commercialization process.” About RevBio, Inc. RevBio, Inc., is a clinical stage medical device company developing and commercializing TETRANITE ®, a patented, synthetic, injectable, self-setting, and osteoconductive adhesive biomaterial. This novel technology will be indicated for use in dental, cranial, and broader orthopaedic applications as well as animal health. TETRANITE is not yet approved for commercial use. View source version on businesswire.com : https://www.businesswire.com/news/home/20241211734903/en/ CONTACT: Michael Tiedemann mtiedemann@revbio.com KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: OTHER HEALTH RESEARCH MEDICAL DEVICES CLINICAL TRIALS SCIENCE SURGERY BIOTECHNOLOGY NEUROLOGY ALTERNATIVE MEDICINE FDA OTHER SCIENCE HEALTH SOURCE: RevBio, Inc. Copyright Business Wire 2024. PUB: 12/11/2024 03:20 PM/DISC: 12/11/2024 03:20 PM http://www.businesswire.com/news/home/20241211734903/en
jili slot free
。
The seamless integration of Amap and Lenovo BaiYing's services simplifies the process of seeking technical support. Users no longer need to search for a reliable computer service provider or navigate through complex troubleshooting procedures. With just a few clicks on the Amap app, users can submit their computer issues and receive prompt assistance from Lenovo BaiYing's team of experts. This streamlined approach not only saves time but also ensures that users receive the best possible solutions to their technical problems.
Man City in danger of exit - how Champions League standsThroughout the conference, participants were treated to a showcase of the latest products and solutions developed by Xiaomi and its partner companies. From smart home devices and connected car technologies to lifestyle gadgets and wearables, attendees had the opportunity to experience firsthand the breadth and depth of the 'Human-Car-Home Full Ecosystem.' The demonstrations sparked excitement and enthusiasm among the audience, hinting at the transformative potential of these integrated solutions in shaping the future of smart living.
NFL will consider replay assist for facemask penalties and other plays
Players who participate in the testing phase will also have the chance to provide valuable feedback to the development team, helping to shape the future of the game and ensure that it meets the expectations of the gaming community.
In addition to their strong league form, Chelsea has also impressed in cup competitions under Tuchel's stewardship. The team has advanced to the later stages of the domestic cups and remains a contender in European competitions, highlighting their ambition and determination to compete on all fronts."We believe that a leaner and more focused team allows us to be more agile and responsive to market demands," Zhang explained. "While it was a difficult decision to make, the results speak for themselves – our organization is now operating with greater efficiency and effectiveness than before."
With both GTA 6 and NS2 set to be released in the same year, analysts are predicting that the gaming industry will witness a surge in sales and revenue, as gamers from around the world flock to get their hands on these highly anticipated titles. The impact of these releases is expected to be felt not only in the gaming community but also in the broader entertainment industry, as these games have the potential to reach a wide audience and leave a lasting impact on popular culture.3. Combat and Skills: In "Infinite Warmth," combat is fast-paced and requires quick reflexes. Familiarize yourself with the attack keys (usually left-click) and special skills (mapped to number keys or function keys) to unleash devastating combos on your opponents. Practice timing your attacks and skills to maximize damage output and outplay your enemies.LISBON (Reuters) - Bukayo Saka scored one goal and set up another as Arsenal thrashed Portuguese side Sporting 5-1 in their Champions League clash at the Estadio Jose Alvalade on Tuesday, their biggest away win in the competition in 21 years. Gabriel Martinelli put Arsenal ahead early on before Kai Havertz and Brazilian defender Gabriel added two more goals before halftime as Arsenal overwhelmed their hosts. Goncalo Inacio pulled a goal back for Sporting early in the second period, but Saka restored Arsenal's three-goal advantage with a penalty and Leandro Trossard got a fifth for their biggest away win in the Champions League since victory by the same scoreline at Inter Milan in 2003. Arsenal moved above Sporting to seventh place in the 36-team table with 10 points from their five games. The Portuguese side have the same number of points but are one position back on goal-difference. (Reporting by Nick Said; Editing by Toby Davis)